Example: air traffic controller

Review of vaccine price data - World Health Organization

Review of vaccine price data Submitted by WHO European Region Member States through the WHO/UNICEF Joint Reporting Form for 2013 Review of vaccine price data Submitted by WHO European Region Member States through the WHO/UNICEF Joint Reporting Form for 2013 World Health Organization 2015 All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to re-produce or translate its publications, in part or in designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization con-cerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

diphtheria and tetanus toxoids and whole-cell pertussis vaccine, paediatric formulation DTwP-Hib-HepB diphtheria and tetanus toxoids and whole-cell pertussis, Haemophilus influenzae type b and hepatitis B vaccine EVAP European Vaccine Action Plan 2015–2020 GNI gross national income GVAP Global Vaccine Action Plan

Tags:

  Toxoid, Diphtheria

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of Review of vaccine price data - World Health Organization

1 Review of vaccine price data Submitted by WHO European Region Member States through the WHO/UNICEF Joint Reporting Form for 2013 Review of vaccine price data Submitted by WHO European Region Member States through the WHO/UNICEF Joint Reporting Form for 2013 World Health Organization 2015 All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to re-produce or translate its publications, in part or in designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization con-cerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

2 Dotted lines on maps represent approximate border lines for which there may not yet be full mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommend-ed by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital reasonable precautions have been taken by the World Health Organization to verify the information contained in this publi-cation.

3 However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. The views expressed by authors, editors, or expert groups do not necessarily represent the decisions or the stated policy of the World Health M. Bring cover WHO page VI WHO/I. Sergienko page 6, 19 & 22 AbstractThis report aims to assist national immunization programme managers, Health budgeting experts and experts responsible for vaccine procurement in accessing, understanding and utilizing available vaccine market information in order to improve the efficiency of vaccine procurement and countries abilities to make financially sustainable, informed decisions on vaccine procurement and new vaccine introduction.

4 It consol-idates data that were collected for the year 2013 and provided by 23 Member States of the WHO European Region through the Joint Reporting Form (JRF) of WHO and the United Nations Children s Fund (UNICEF). The report provides a brief overview of the availability and transparency of vaccine pricing informa-tion at the country level, the vaccine procurement mechanisms, the procured vaccines and vaccine price information for each of the individual vaccine products. Individual procurement records include some of the variables expected to have a potential im-pact on price , including the country income group, volume of procurement, product formulation and presentation, delivery terms and vaccine procurement ANALYSISPRICINGUNICEFVACCINESWORLD Health ORGANIZATIONISBN 978 92 890 5107 1 Address requests about publications of the WHO Regional Office for Europe to.

5 PublicationsWHO Regional Office for EuropeUN City, Marmorvej 51DK-2100 Copenhagen , DenmarkAlternatively, complete an online request form for documentation, Health information, or for permission to quote or translate, on the Regional Office website ( ). IIIACKNOWLEDGEMENTS .. IVABBREVIATIONS .. VINTRODUCTION .. 1 GLOBAL RECOGNITION OF THE NEED FOR vaccine price TRANSPARENCY .. 1 WHO EUROPEAN REGION RESPONSE ON vaccine price TRANSPARENCY .. 2 REPORTING OF vaccine price 3 AVAILABILITY AND TRANSPARENCY OF vaccine PRICING INFORMATION.

6 4 vaccine PROCUREMENT MECHANISMS .. 5 PROCURED VACCINES .. 7 MANUFACTURER BASE OF PROCURED VACCINES .. 9 REPORTED vaccine PRICES .. 11 COUNTRY INCOME LEVEL AND vaccine PRICES PAID .. 13 vaccine PROCUREMENT VOLUMES AND price .. 14 vaccine PRESENTATION AND price .. 15 vaccine FORMULATION AND price .. 15 WHO S V3P PLATFORM .. 18 REFERENCES .. 20 APPENDIX 1. JRF TEMPLATE USED TO COLLECT vaccine PRICING DATA FOR 2013 .. 23 APPENDIX 2. MEMBER STATES REPORTING STATUS OF vaccine PRICING DATA IN THE ANNUAL WHO/UNICEF JRF, 2013 .. 24 APPENDIX 3.

7 COUNTRY-SPECIFIC vaccine price DATA BY INDIVIDUAL PRODUCT .. 25 APPENDIX 4. NATIONAL CURRENCY EXCHANGE RATES TO US DOLLARS .. 41 APPENDIX 5. CLASSIFICATION OF MEMBER STATES BY COUNTRY INCOME GROUP .. 43 APPENDIX 6. LIST OF WHO PREQUALIFIED VACCINES AS OF 1 JANUARY 2015 .. 45 APPENDIX 7. OTHER vaccine price DATA SOURCES .. 51 ContentsAcknowledgementsThis publication was developed by the vaccine -preventable Diseases and Immunization Programme of the WHO Regional Office for Europe and was coordinated by Oleg Benes, Technical Officer at the Regional Office, within the framework of the global WHO vaccine Product, price and Procurement (V3P) Project.

8 The following individuals have contributed to the production of the publication and their inputs are acknowledged with sincere gratitude: Shawn S. Gilchrist, independent consultant; Sarah Schmitt, independent consultant, financing, planning and procurement; Stephanie Mariat, vaccine Product, price and Procurement (V3P) Project, WHO headquarters; Tania Cernuschi, Technical Officer, vaccine Pricing, Supply and Procurement, WHO headquarters; Michael Hinsch, independent consultant, vaccine Product, price and Procurement (V3P) Project, WHO headquarters; Miloud Kaddar, Health Economist, WHO headquarters.

9 Catharina de Kat-Reynen, Consultant, vaccine -preventable Diseases and Immunization, WHO Regional Office for Europe. VAbbreviationsaP acellular pertussisBCG bacille Calmette Gu rin (tuberculosis) vaccineDT diphtheria and tetanus tox-oids, paediatric formulationDTaP diphtheria and tetanus tox-oids and acellular pertussis vaccine , paediatric formu-lationDTaP-Hib diphtheria and tetanus tox-oids and acellular pertussis and Haemophilus influenzae type b vaccineDTaP-Hib-HepB-IPV diphtheria and tetanus tox-oids and acellular pertussis, Haemophilus influenzae type b, hepatitis B and inactivated poliovirus vaccineDTaP-Hib-IPV diphtheria and tetanus toxoids and acellular pertus-sis.

10 Haemophilus influenzae type b and inactivated poliovirus vaccineDTaP-IPV diphtheria and tetanus tox-oids and acellular pertussis and inactivated poliovirus vaccineDT-IPV diphtheria and tetanus toxoids and inactivated poliovirus vaccineDTP diphtheria tetanus pertus-sis vaccineDTwP diphtheria and tetanus toxoids and whole-cell pertussis vaccine , paediatric formulationDTwP-Hib-HepB diphtheria and tetanus toxoids and whole-cell pertussis, Haemophilus influenzae type b and hepatitis B vaccineEVAP European vaccine Action Plan 2015 2020 GNI gross national incomeGVAP Global vaccine Action PlanHepA hepatitis A vaccineHepAHepB hepatitis A and hepatitis B vaccineHepB_adult hepatitis B vaccine , adult formulationHepB_paediatric hepatitis B vaccine .


Related search queries